Skip to content

An AIB investment

LabCycle

Recycling of laboratory plastic waste

Purpose

The opportunity

LabCycle is the first company on the market to create a circular economy for single-use plastic waste from Safety Level 1 & 2 labs and healthcare settings..

5.5M tonnes of lab plastics annually in the biomedical sector alone is incinerated. LabCycle decontaminates and sells the high-grade plastic waste to create the world’s first 100% recycled lab products.

Rationale

Why We Invested

A combination of team credibility, sustainable purpose and market opportunity led AIB to support LabCycle. The company has won a number of awards and is now accelerating their scalability.

We’re proud to be co-investing along side QantX, Angel Academe and a number of other private angels. LabCycle is also part of the NHS Accelerator (NHS England Health Innovation Network), which gives companies access into the NHS network.

Future

Use of Funds

With a huge prospect pipeline opportunity, the investment will support plans to move to a larger facility and grow the team allowing LabCycle to service the growing customer base.

Further Reading

Links / News

LabCycle website / LinkedIn.

LabCycle

This investment enables us to: Increase processing capacity with a new site, scale our proprietary recycling technology and expand our team.

Colin Francis | CEO & Founder

Real impact. Real startups

Related investments

Discover the startups our members are backing across the South West and South Wales. Explore recent investments and see the impact we’re making.

Ready to shape the
future together?

Back the South West and South Wales’ most ambitious founders and grow your portfolio with us. Whether you’re new or experienced, Angel Investors Bristol gives you the network, insight, and opportunities to make real impact.